This ANZAC Day 2023, Australian Health Journal releases an interview with Group Captain Kath Stein MACN, Director of Defence Force Nursing with the Royal Australian Air Force.
She talks about many masks, aside from PPE, that leadership and all nurses need to wear. Currently there is work underway on a new capability description on what a nurse brings to every level in the nursing defence structure. The advice Group Captain Stein, imparts for new recruits and those interested in joining Defence Force Nursing is to take every opportunity that arises. This is evident in her progression through her career.
Group Captain Stein joined the Air Force in March 1991 through the Undergraduate Scheme. Following her graduation from University she consolidated her clinical training in the Graduate Program at Fremantle Hospital.
In the years that have followed she has served in health facilities including Number 3 RAAF Hospital, Health Services Flights Pearce and Tindal with operational experience on exercises and deployments. This health experience supported her health planning role in Headquarters 395 Expeditionary Combat Support Wing and varying policy and governance roles in Strategic Policy and Intelligence Group, Joint Health Command and Air Force Headquarters. She was privileged to Command Joint Health Unit Northern New South Wales and is the current Director of Defence Force Nursing.
Group Captain Stein’s professional development activities have included the USAF Flight Nurse Course and tertiary studies to specialise in Trauma Nursing and Emergency Management. She recently Graduated from the Australian Institute of Company Directors and has served as a Director on the Board for a Not for Profit Organisation making a difference in Mental Health Services for the community. Her interests outside of work include supporting her childrens’ sporting pursuits, catching up with friends and community service. She has two teenage boys and indulges one very spoilt puppy, Alfie.
Credits:
Australian College of Nursing (National Nursing Forum 2022, Darwin),
Adjunct Professor Kylie Ward FACN, CEO ACN
-
World-first clinical trial improves patient outcomes for kidney transplants
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Australian Health Journal spoke with the lead-author of the study, RAH Nephrologist and University of Adelaide researcher, Dr Michael Collins.
-
Misinformation impacts routine vaccines
More significant changes in recent years have been health-related misinformation eroding trust in healthcare professionals, leading to people seeking alternative treatments or avoiding medical advice altogether. This can make it more difficult for healthcare professionals to provide effective treatment and care.
Recent vaccines delivered as part of the COVID-19 response, are having a consequential impact on the uptake of routine vaccines.
Australian Health Journal spoke with Dr Paul Griffin, an Infectious Diseases Physician and Microbiologist at Mater Health, and who has been involved in over 150 clinical trials in the field of infectious disease.
Paul talks about the importance of having reputable sources of information that can used to encourage people to understand what is involved in clinical trials and the roles of vaccines.
-
A clinical research career working Sponsor-side, CRO-side to Site-side
In July 2025, Paratus Clinical, a Australian provider of dedicated clinical trial services, announced the appointment of Megan Morrison as its new Chief Executive Officer, at the same time as a significant milestone as the company celebrating over a decade of impact in the clinical research space. Paratus now operates a network of five purpose-built, research-only clinics along Australia’s eastern seaboard.
